Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment
- PMID: 36233085
- PMCID: PMC9569873
- DOI: 10.3390/ijms231911780
Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment
Abstract
The metrological properties of two performance-based outcome measures of feline osteoarthritis (OA), namely Effort Path (Path) and Stairs Assay Compliance (Stairs), were tested. Cats naturally affected by OA (n = 32) were randomly distributed into four groups (A: 0.40, B: 0.25, C: 0.15, or D: 0.00 mg firocoxib/kg bodyweight) and assessed during baseline, treatment, and recovery periods. For Path, from an elevated walking platform, the cats landed on a pressure-sensitive mattress and jumped up onto a second elevated platform. Analysis included velocity, time to completion, peak vertical force (PVF), and vertical impulse. For Stairs, the number of steps and time to completion were recorded for 16 steps up and down in a 4 min period. Reliability was moderate to very good for Path and poor to good for Stairs. Different normalization methods are described in the manuscript. The placebo group remained stable within-time in Path, whereas treated cats trotted faster on the ramp (p < 0.0001), improved their PVF (p < 0.018) and completed the task quicker (p = 0.003). The percentage of cats completing the Stairs finish line was higher under treatment (p < 0.036), with huge effect size, the placebo group results being stable within-time. Both are promising performance-based outcome measures to better diagnose and manage feline OA pain.
Keywords: feline; firocoxib; gait analysis; osteoarthritis; performance; stairs.
Conflict of interest statement
The authors declare no conflict of interest. M.D. is a regular employee of Boehringer Ingelheim Animal health, Inc.; M.M. is regular employee of ArthroLab Inc.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9569873/bin/ijms-23-11780-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9569873/bin/ijms-23-11780-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9569873/bin/ijms-23-11780-g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9569873/bin/ijms-23-11780-g004.gif)
Similar articles
-
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study.Animals (Basel). 2024 Feb 24;14(5):711. doi: 10.3390/ani14050711. Animals (Basel). 2024. PMID: 38473097 Free PMC article.
-
A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis.Int J Mol Sci. 2022 Sep 8;23(18):10384. doi: 10.3390/ijms231810384. Int J Mol Sci. 2022. PMID: 36142319 Free PMC article. Review.
-
The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.BMC Vet Res. 2019 Oct 17;15(1):349. doi: 10.1186/s12917-019-2110-7. BMC Vet Res. 2019. PMID: 31623621 Free PMC article.
-
Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis.PLoS One. 2017 Apr 12;12(4):e0175565. doi: 10.1371/journal.pone.0175565. eCollection 2017. PLoS One. 2017. PMID: 28403198 Free PMC article. Clinical Trial.
-
Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database.Osteoarthritis Cartilage. 2011 May;19(5):483-92. doi: 10.1016/j.joca.2011.02.020. Epub 2011 Mar 23. Osteoarthritis Cartilage. 2011. PMID: 21396467 Review.
Cited by
-
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study.Animals (Basel). 2024 Feb 24;14(5):711. doi: 10.3390/ani14050711. Animals (Basel). 2024. PMID: 38473097 Free PMC article.
-
Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0.Int J Mol Sci. 2023 Jun 15;24(12):10166. doi: 10.3390/ijms241210166. Int J Mol Sci. 2023. PMID: 37373313 Free PMC article.
References
-
- Nielsen L.M., Kirkegaard H., Østergaard L.G., Bovbjerg K., Breinholt K., Maribo T. Comparison of self-reported and performance-based measures of functional ability in elderly patients in an emergency department: Implications for selection of clinical outcome measures. BMC Geriatr. 2016;16:199. doi: 10.1186/s12877-016-0376-1. - DOI - PMC - PubMed
-
- Dobson F., Hinman R.S., Roos E.M., Abbott J.H., Stratford P., Davis A.M., Buchbinder R., Snyder-Mackler L., Henrotin Y., Thumboo J., et al. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthr. Cartil. 2013;21:1042–1052. doi: 10.1016/j.joca.2013.05.002. - DOI - PubMed
-
- Guedes A.G.P., Meadows J.M., Pypendop B.H., Johnson E.G., Zaffarano B. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats. J. Am. Vet. Med. Assoc. 2018;253:579–585. doi: 10.2460/javma.253.5.579. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous